Latest news
Why CAR T-Cell Therapy Should Precede Bispecifics in Multiple Myeloma - CancerNetworkCancerNetwork · Fri, 07 Aug 2026 15:09:51 GMTClinical Implications of Earlier CAR-T Therapy in Relapsed/Refractory Multiple Myeloma - CancerNetworkCancerNetwork · Wed, 05 Aug 2026 12:14:23 GMTCARTITUDE-4 Supports Earlier CAR-T Use in Relapsed/Refractory Multiple Myeloma - CancerNetworkCancerNetwork · Wed, 05 Aug 2026 12:09:23 GMTCELMoDs Have “a Lot of Potential” in Multiple Myeloma Treatment Landscape - CancerNetworkCancerNetwork · Mon, 03 Aug 2026 18:00:00 GMTSequencing CAR T-Cell Therapy and Bispecific Antibodies at First Relapse in Relapsed/Refractory Multiple Myeloma - CancerNetworkCancerNetwork · Mon, 03 Aug 2026 12:08:53 GMTSneak Peek: Practical CAR T Cell Use in Multiple Myeloma Care - CancerNetworkCancerNetwork · Fri, 31 Jul 2026 19:08:12 GMT